12-Didecanoyl-sn-glycero-3-phosphocholi
CAS No. 3436-44-0
12-Didecanoyl-sn-glycero-3-phosphocholi( 12-Didecanoyl PC | 12-Didecanoyl Phosphatidylcholine )
Catalog No. M19855 CAS No. 3436-44-0
12-Didecanoyl-sn-glycero-3-phosphocholi is a synthetic less hydrophobic phospholipid that has been found to be useful for enhancing the absorption of peptide drugs and hormones such as insulin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name12-Didecanoyl-sn-glycero-3-phosphocholi
-
NoteResearch use only, not for human use.
-
Brief Description12-Didecanoyl-sn-glycero-3-phosphocholi is a synthetic less hydrophobic phospholipid that has been found to be useful for enhancing the absorption of peptide drugs and hormones such as insulin.
-
Description12-Didecanoyl-sn-glycero-3-phosphocholi is a synthetic less hydrophobic phospholipid that has been found to be useful for enhancing the absorption of peptide drugs and hormones such as insulin.
-
In Vitro——
-
In Vivo——
-
Synonyms12-Didecanoyl PC | 12-Didecanoyl Phosphatidylcholine
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3436-44-0
-
Formula Weight565.72
-
Molecular FormulaC28H56NO8P
-
Purity>98% (HPLC)
-
SolubilityDMSO: 30 mg/mL
-
SMILESCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
RCGD423
RCGD423 a small molecule gp130 modulator prevents articular cartilage degeneration and promotes repair.
-
Ribitol
At equivalent molar concentrations, both the salt and free forms of a compound exhibit comparable biological activity. Nevertheless, the salt form (Fosfructose trisodium) usually boasts enhanced water solubility and stability.
-
Atacicept
Atacicept (TACI-Ig) is a homodimeric fusion protein that inhibits B-cell stimulation by binding to B-lymphocyte stimulatory factors and proliferation-inducing ligands, and can be used in the study of systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, multiple sclerosis, and various B-cell malignancies.
Cart
sales@molnova.com